A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement

NCT05542277 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
130
Enrollment
INDUSTRY
Sponsor class

Stopped The study was stopped to evaluate the differences between the indications.

Conditions

Interventions

Sponsor

PlasFree Ltd.